BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Matuszcak C, Haier J, Hummel R, Lindner K. MicroRNAs: Promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential. World J Gastroenterol 2014; 20(38): 13658-13666 [PMID: 25320504 DOI: 10.3748/wjg.v20.i38.13658]
URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13658.htm
Number Citing Articles
1
Jian Wang, Qiong Niu, Ning Shi, Chengxia Liu, Haifeng Lian, Jiancheng Li, Kun Li. Long non-coding RNA NEAT1 decreases the chemosensitivity of gastric cancer cells via regulating P-glycoprotein expressionMolecular & Cellular Toxicology 2017; 13(3): 317 doi: 10.1007/s13273-017-0035-4
2
Junhua Gong, Zheng Cui, Li Li, Qiang Ma, Qiufang Wang, Yinhe Gao, Hao Sun. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7Tumor Biology 2015; 36(10): 7831 doi: 10.1007/s13277-015-3510-3
3
Jiazhuan Mei, Guiju Liu, Ruijun Li, Peng Xiao, Dan Yang, Hua Bai, Yibin Hao. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axisBioscience Reports 2021; 41(12) doi: 10.1042/BSR20211885
4
Chuchu Chen, Yi Hui, Yunzhao Chen, Chengjia Qian, Minxuan Sun. Loss of c-Cbl expression correlates with de-differentiation status and lymphatic metastasis in gastric cancerIndian Journal of Pathology and Microbiology 2019; 62(4): 549 doi: 10.4103/IJPM.IJPM_824_18
5
Jinyan Zhao, Weilan Lan, Jun Peng, Bin Guan, Jie Liu, Min Zhang, Zhixue Zhan, Jiumao Lin, Daniela Russo. Babao Dan Reverses Multiple-Drug Resistance in Gastric Cancer Cells via Triggering Apoptosis and Autophagy and Inhibiting PI3K/AKT/mTOR SignalingEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5631942
6
Kaifeng Qiu, Zixian Huang, Zhiquan Huang, Zhichao He, Siping You. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinomaArchives of Oral Biology 2016; 66: 92 doi: 10.1016/j.archoralbio.2016.02.013
7
Najibeh Shekari, Faezeh Asghari, Navideh Haghnavaz, Dariush Shanehbandi, Vahid Khaze, Behzad Baradaran, Tohid Kazemi. Let-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric CancerAnti-Cancer Agents in Medicinal Chemistry 2019; 19(3): 304 doi: 10.2174/1871520619666181213110258
8
Chao Chen, Xiaohuan Tang, Yuanda Liu, Jiaming Zhu, Jingjing Liu. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review)International Journal of Oncology 2019;  doi: 10.3892/ijo.2019.4751
9
Yanghee Woo, Carolyn E. Behrendt, Annie Yang, Maria Hahn, Ajay Goel, Haiqing Li, Yate-Ching Yuan, Yuman Fong. Tumor Epigenetic Signature and Survival in Resected Gastric Cancer PatientsJournal of the American College of Surgeons 2021; 232(4): 483 doi: 10.1016/j.jamcollsurg.2020.12.023
10
Yang Liu, Yu Zhou, Xun Gong, Changjie Zhang. MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptorExperimental and Therapeutic Medicine 2017; 14(1): 173 doi: 10.3892/etm.2017.4477
11
Chuanyao Cheng, Yaguang Qin, Qiongjie Zhi, Jianjun Wang, Changjiang Qin. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34aInternational Journal of Biological Macromolecules 2018; 107: 2620 doi: 10.1016/j.ijbiomac.2017.10.154
12
Showkat Ahmad Bhat, Sabhiya Majid, Tehseen Hassan. MicroRNAs and its emerging role as breast cancer diagnostic marker- A reviewAdvances in Biomarker Sciences and Technology 2019; 1: 1 doi: 10.1016/j.abst.2019.05.001
13
Yujiang Peng, Xijun He, Huihui Chen, Hongyu Duan, Bo Shao, Fan Yang, Huiyong Li, Pengxiang Yang, Yu Zeng, Jinrong Zheng, Yongsheng Li, Jiachang Hu, Liguo Lin, Lingfang Teng. Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathwayBioscience Reports 2018; 38(5) doi: 10.1042/BSR20181051
14
Haifeng Gao, Jiajia Xu, Fen Qiao, Liangjun Xue. Depletion of hsa_circ_0000144 Suppresses Oxaliplatin Resistance of Gastric Cancer Cells by Regulating miR-502-5p/ADAM9 AxisOncoTargets and Therapy 2021; : 2773 doi: 10.2147/OTT.S281238
15
Hong W Yu, William C Cho. The emerging role of miRNAs in combined cancer therapyExpert Opinion on Biological Therapy 2015; 15(7): 923 doi: 10.1517/14712598.2015.1030390
16
Hem D. Shukla, Javed Mahmood, Zeljko Vujaskovic. Integrated proteo-genomic approach for early diagnosis and prognosis of cancerCancer Letters 2015; 369(1): 28 doi: 10.1016/j.canlet.2015.08.003
17
Catherine E Steding. Creating chemotherapeutic-resistant breast cancer cell lines: advances and future perspectivesFuture Oncology 2016; 12(12): 1517 doi: 10.2217/fon-2016-0059
18
Sadegh Fattahi, Fatemeh Amjadi-Moheb, Reza Tabaripour, Gholam Hossein Ashrafi, Haleh Akhavan-Niaki. PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyondLife Sciences 2020; 262: 118513 doi: 10.1016/j.lfs.2020.118513
19
Ying Wang, Kaijuan Lu, Weibing Li, Zhigang Wang, Jing Ding, Zeyu Zhu, Zhipeng Li. MiR-200c-3p aggravates gastric cell carcinoma via KLF6Genes & Genomics 2021; 43(11): 1307 doi: 10.1007/s13258-021-01160-6
20
Tengkai Wang, Rui Ji, Guanqun Liu, Beilei Ma, Zehua Wang, Qian Wang. Lactate induces aberration in the miR-30a–DBF4 axis to promote the development of gastric cancer and weakens the sensitivity to 5-FuCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02291-2
21
GUANGYAN LI, FANG YANG, SHIYU GU, ZHENJUAN LI, MINGHUI XUE. MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-CMolecular Medicine Reports 2016; 13(1): 572 doi: 10.3892/mmr.2015.4560
22
Yunhao Ma, Hao Xu, Zhongkun Zhou, Yanan Tian, Kangjia Du, Hao Zhang, Xinrong Jiang, Juan Lu, Yuqing Niu, Lixue Tu, Huanxiang Liu, Hongmei Zhu, Peng Chen, Yingqian Liu. CFNC, a neocryptolepine derivative, inhibited the growth of gastric cancer AGS cells by inhibiting PI3K/AKT signaling pathwayEuropean Journal of Pharmacology 2023; 938: 175408 doi: 10.1016/j.ejphar.2022.175408